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Olson. A Seven-Year Retrospective Cohort Study 
ABSTRACT 
Purpose: 
To identify potential risk factors associated with post-cataract surgery bacterial endophthalmitis. 
Setting: 
The John A. Moran Eye Center. 
Design: 
Retrospective cohort study. 
Methods: 
Patient or Study Population: Patients operated on for cataract(s) at this eye hospital. 
Intervention or Observation Procedure(s): 10% sampling of all patients operated on for cataract surgery from 1-1-96 
to 12-31-02 were compared with all cases of post -cataract surgery bacterial endophthalmitis during this same time 
period at this institution. 
Main Outcome Measure(s): Surgical complication, first postoperative day wound leak, incision placement and 
location, intraocular lens material, if a suture is placed, antibiotic used, collagen shield use, and whether patched. 
Results: 
1525 patients were in the control cohort and there were 27 cases of endophthalmitis. In a multivariate regression 
analysis those factors found to be statistically associated with endophthalmitis were: 1. wound leak on the first 
postoperative day (O.R. 44 ± 42; C.I 6.85 to 287; P<O.OOl); 2. capsular or zonular surgical complication (O.R. 17.2 
± 14.2; c.1. 3.44 to 86.4; P=O.OOl); 3. topical antibiotic started the day after surgery rather than the day of surgery 
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(O.R. 5.3 ± 3.6; c.1. 1.41 to 20.0; P=0.0l4); 5. not patching after surgery (O.R. 7.1 ± 5.6; C.1. 1.47 to 36.4; 
P=0.0l5); and 6. not placing a collagen shield soaked in antibiotic (O.R. 2.7 ± 1.3; C.1. 1.06 to 7.14 P=0.037) 
Conclusions: 
In sutureless cataract surgery, surgical complications and wound leak on the first postoperative day were most 
strongly associated with endophthalmitis. 
Synopsis: 
In sutureless clear corneal incisions, complications exposing vitreous or leaky wound was associated with increased 
endopthalmitis risk. Antibiotics used the day of surgery and a collagen shield soaked in antibiotics were associated 
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INTRODUCTION 
Endophthalmitis has historically been about 0.1 %1 and yet sutureless, corneal surgery has been shown in a 
randomized study to statistically significantly increase this risk2• At the same time most institutions have also 
abandoned subconjunctival antibiotic injections because of the discomfort and have switched to topical 
fluoroquinolones as the mainstay of antibiotic prophylaxis. All of these changes leave unanswered questions about 
the best approaches to minimize post-surgical endophthalmitis risk. 
In an internal quality control study (Jensen MK, Fiscella RO. Comparison of endophthalmitis rates over four years 
associated with topical ofloxacin vs. ciprofloxacin. Invest Ophthalmol Vis Sci 2002; 43(12):4429), we found that the 
choice of antibiotic could be important in the incidence of post-surgical endophthalmitis3. This study has now been 
expanded to a seven-year review representing over 15,000 cataract surgeries at one institution. We have included a 
control cohort representing 10% of all surgeries and have used original source documents in regard to all 
information gathered from the cohort control group as well as the endophthalmitis group. We would like to report 
our results from this retrospective cohort study. 
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METHODS 
All cataract surgeries (no combined surgeries) between January 1, 1996 and December 31, 2002 at the John A. 
Moran Eye Center were included in the study. In the same period of time, all cases of bacterial endophthalmitis 
from our original quality control database were included, as well as a review of all cases with the diagnosis of 
C endophthalmitis, a review of all cases where a culture was taken in the operating room, and all cultures submitted as 
C 
~ either aqueous or vitreous culture, to ascertain that we included all cases of bacterial endophthalmitis during the 





~ ~ Every tenth consecutive chart starting from January 1, 1996 of patients operated were reviewed and included in our 
~ 
C 
~ cohort study. If the clinical chart was not available, then the 9th chart in order was reviewed and if it was not 
~. 
"'0 
rt available then the 11th chart was reviewed. Using this system, all charts were available for an exact 10% sampling 
C 
C 
of all patients. 
The information collected on each patient included patient age, gender, date of surgery, surgeon, anesthesia used, 
preoperative antibiotic used, listing of the surgical complication of capsular rupture or zonular dehiscence, 
intraocular lens used, whether a suture or collagen shield was used, whether the incision was temporal or superior, 
whether the incision was scleral or limbal/corneal, whether the eye was patched, postoperative antibiotic used and 
frequency of use, whether antibiotic was started on the day of surgery, and whether any complication was noted on 
the first postoperative day (specifically a wound leak). There was no control for surgical technique variations except 
these that are listed. A collagen shield when used was always soaked in 0.5-ml of cefazolin (lOO-mg/ml) and 0.5-ml 
of dexamethasone (4 mg/ml). Antibiotics were not used intraocularly or in the irrigating fluid for any of these cases. 
Subconjunctival antibiotics were only used in some scleral incision cases. For cases of endophthalmitis, the date 
that the infection was first noted, the final visual acuity attained, and culture results were also determined. 
Because topical Betadine was used prior to surgery in every case, except where the patient was allergic to iodine, 
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Data was entered into Microsoft Excel 2000 and imported into STATA version 8 (College Station, TX). Summary 
statistics were calculated and used to characterize all control and endophthalmitis cases in terms of age, gender, type 
of anesthesia, type and location of incision, type of IOL, type of pre-operative and post-operative antibiotic, whether 
a collagen shield was used, suture status of the wound, whether a surgical complication or wound leak was noted, 
and if antibiotic therapy was started the day of surgery. Incidence of endophthalmitis per surgeon was also 
determined. 
Univariate logistic regression models were used to predict development of endophthalmitis based on each study 
variable. Multivariate logistic regression was used to examine the development of endophthalmitis among study 
subjects whereby all factors used in the univariate models were inserted to determine which surgical factors emerge 
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RESULTS 
1,525 charts were reviewed representing 15,254 cataract surgeries. Incidence of endophthalmitis per surgeon was 
not statistically different. During this seven-year period of time there were 27 cases of presumed endophthalmitis of 
which 20 were culture positive. A multi-variant regression analysis was performed but did not include a scleral or 
superior incision or retrobulbar anesthesia (all three were almost completely concordant) because there were no 
cases of endophthalmitis for these approaches and, therefore, an odds ratio could not be determined (they predicted 
success perfectly). Looking, therefore, at all other variables, those that were statistically associated with the 
diagnosis of endophthalmitis were (Tables 1 & 2): 
1. A wound leak noted on the first postoperative day (odds ratio 44.4 ± 42.3; 95% confidence intervals 6.85 to 
287.4; P<O.OO1 for all cases and 21.4 ± 25.7; 95% confidence intervals 2.02 to 226.4; P=O.Oll for culture 
positive cases). 
2. Breaking the capsule or zonular dehiscence at the time of surgery (odds ratio 17.2 ± 14.2; 95% confidence 
intervals 3.44 to 86.4; P=O.OO1 for all cases and 17.8 ± 16.2; 95% confidence intervals 3.01 to 105.4; 
P=0.002 for culture positive cases). 
3. Antibiotics started on the first postoperative day rather than on the day of surgery. (odds ratio 13.7 ± 12.9; 
95% confidence intervals 2.17 to 90.9; P=0.005 for all cases and 15.9 ± 15.9; 95% confidence intervals 
2.27 to Ill; P=0.006 for culture positive cases). 
4. Ciprofloxacin used rather than ofloxacin (these two represent over 99% of topical antibiotic used during 
this period) as the post-operative antibiotic (odds ratio 5.26 ± 3.60; 95% confidence intervals 1.41 to 20; 
P=0.014 for all cases and 7.14 ± 5.61; 95% confidence intervals 1.61 to 32.3; P=0.009 for culture positive 
cases). 
5. The eye not patched after surgery (odds ratio 7.14 ± 5.61; 95% confidence intervals 1.47 to 36.4; P=0.015 
for all cases and 9.1 ± 9.1; 95% confidence intervals 1.33 to 62.5; P=0.025 for culture positive cases). 
6. Collagen shield soaked in cefazolin (l00 mg/rnl) and dexamethasone (4 mg/rnl) not used after surgery 
(odds ratio 2.70 ±1.31; 95% confidence intervals 1.06 to 7.14; P=0.037 for all cases; Not significantly 
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7. The use of a silicone rather than an acrylic intraocular lens (odd ratio 2.63 ± 1.29; P=O.048 for all cases; 
N.S. in culture positive cases; P=O.36). 
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DISCUSSION 
Endophthalmitis is a devastating complication, so understanding what we might do to prevent it is of great clinical 
importance. A study such as this can only find relationships and not causality. We did find potentially important 
issues. Our most important relationship from this study is the dramatically increased risk associated with capsular 
C breakage or zonular damage at surgery and a wound leak on the first postoperative day. All cases of 
C 
~ endophthalmitis were from cases with sutureless, clear corneal incisions with no infections noted in 1,200 cases with 
> C superior, scleral incisions. Vitrectomy with cataract surgery has been known to increase the risk of endophthalmitis 
rt 
:::r" Q about four fold l ; however, our results show a much higher odds ratio (17 to 18 fold for all cases and culture positive 
~ ~ cases) than has been reported. Little is known about endophthalmitis as it correlates with capsular breakage in cases 
~ 
C 
~ with sutureless incisions. The contamination concern from micro-leaks after sutureless incisions makes capsular 
~. 
""0 
rt breakage in this scenario an important consideration. 
C 
C 
A recent prospective, randomized study showed that sutureless corneal or limbal incisions can increase the risk of 
endophthalmitis over scleral incisions2. A broken capsule with vitreous exposed to direct bacterial contamination 
deserves special attention in sutureless, clear corneal cases. Cases of capsular or zonular breakage should probably 
have a suture placed to minimize the risk of further postoperative contamination. Interestingly, our results suggest 
sutures increase the endophthalmitis risk. On further evaluation, this association did not stand after a multivariate 
analysis. This is most likely explained by the fact that sutures were placed in complicated cases which are more 
likely to have endophthalmitis. 
Our greatest association was a leaky wound on the first postoperative day, which supports our overall hypothesis 
that postoperative contamination of the eye is an important potential problem with sutureless limbal or corneal 
incisions. With a 44-fold increased risk (21 fold for culture positive cases), such eyes require increased and careful 
scrutiny. A suture should probably be placed when the leak is discovered in combination with the use of appropriate 
and frequent topical and possibly oral antibiotics when you consider the risk of endophthalmitis in our series was 1 
in 55. These patients deserve frequent contact and a thorough discussion of the signs and symptoms of 
endophthalmitis. Any sign of increased inflammation during the week should be considered endophthalmitis. Even 
Page 10 
Olson. A Seven-Year Retrospective Cohort Study 
though we were aware in early 2001 that the antibiotic used may have great importance in the prevention of 
endophthalmitis and that wound leakage in sutureless incisions with micro-leaks and micro-contamination probably 
explained our increased incidence of endophthalmitis, one of our four cases of endophthalmitis in 2001 was 
secondary to a wound leak and the only case in 2002 was secondary to such a complication. 
C The use of topical ciprofloxacin postoperatively, not using a collagen shield, not patching and waiting until the fIrst 
C 
~ postoperative day to start topical antibiotics were also associated with endophthalmitis. All four factors , we feel, 
> C further support our hypothesis about topical or clear cornea micro-leaks and anterior chamber contamination. 
rt 
:::r"' Q Ciprofloxacin generally does as good ajob as ofloxacin in eliminating superficial contamination4 ; however, our high 
~ ~ incidence of endophthalmitis is probably due to micro-leaks after surgery. The main difference between 
~ 
C 
~ ciprofloxacin and ofloxacin is the fact that ofloxacin penetrates into the anterior chamber about four times more 
~. 
""0 
rt readily than ciprofloxacin5,6 and therefore, with frequent topical usage, therapeutic levels can more easily be reached 
C 
C 
in the anterior chamber and potentially eliminate micro-contamination thereby preventing a case of endophthalmitis 
that otherwise might have occurred. This closely correlates with our protective effect with the collagen shield. As it 
dissolves, the shields (twelve-hour shields were used) add cefazolin (100 mg/ml) into the eye. All of our positive 
culture cases were gram positive bacteria, and cefazolin works well on most gram-positive bacteria. The shield may 
also exert a barrier effect or even help support the wound in the early postoperative period. 
Placing a patch was also found to be protective. We feel the patch also has a dual mechanism of action in that a 
collagen shield without a patch is often blinked out of the eye within 5-10 minutes. The patch ensures that a 
collagen shield stays in place so that the shield can work. Additionally, the patch itself may also be important in the 
early postoperative period in keeping the wound closed. Interestingly, our results also showed that starting topical 
antibiotics the day of surgery significantly prevented endophthalmitis. It would seem that the use of a patch and 
antibiotics the day of surgery may be mutually exclusive. At our institution, however, when patches are used with 
collagen shields to keep the shield in place during the early postoperative period, the patch was often placed for four 
or five hours and then antibiotic drops were placed everyone to two hours for the rest of the day. Our study 
supports this approach. 
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Another issue of importance is bacterial resistance. During most of the study period, ciprofloxacin and ofloxacin 
resistance was not a common problem. Resistance, however, has become an increasingly important issue for these 
second generation fluoroquinolones7,8. Fluoroquinolone resistance was not routinely measured in our series and 
then only for ciprofloxacin. Only 15 cases were tested for ciprofloxacin resistance and all were listed as sensitive. 
C As further evidence of the importance of an antibiotic which provides therapeutic intraocular concentrations, largely 
C 
~ using ofloxacin, we had only one case of endophthalmitis in 2002 in over 2500 cataract surgeries and this patient 





~ ~ The final independent risk associated with endophthalmitis was the use of silicone intraocular lenses. There is no 
~ 
C 
~ obvious reason why there should be a difference. There is no evidence that silicone, as a material, is more likely to 
~. 
""0 
rt be contaminated or have unusual bacterial adherence. Furthermore, when looking at only culture positive cases this 
C 
C 
significant difference was not corroborated (P=.361 in our multivariate analysis and .652 in an univariate analysis). 
This suggests this finding is a statistical anomaly especially considering the Nagaki et al. prospective, randomized, 
clinical trial2 which showed no endophthalmitis difference between acrylic and silicone lenses. This issue does 
deserve further scrutiny. 
This endophthalmitis study suggests some steps in regard to endophthalmitis prevention. These considerations are: 
1. Patients with a capsular or zonular break with limbal or clear corneal incisions as well as any marginal 
incision likely to leak probably deserves a suture. If in doubt, a suture should be placed to minimize the 
risk of contamination. 
2. A collagen shield soaked in antibiotic should be considered. Although we have used cefazolin to soak the 
shield, the antibiotic should probably be changed based upon present-day resistance. New 
flouroquinolones (gatifloxacin and moxifloxacin) are logical candidates in light of second generation 
fluoroquinolone resistance6,7. Exactly what dosage in relation to epithelial toxicity this might be is the 
subject of another ongoing study. Furthermore, having the antibiotic from the collagen shield the same as 
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results. Additionally the collagen shield should be of the shortest duration available. The role of 
subconjunctival antibiotics can not be analyzed from this study because so few subconjunctival injections 
were placed with none placed in the cases of endophthalmitis. 
3. The eye should possibly be patched, to both help control the wound and keep the collagen shield in place. 
The patching itself should probably be for approximately four hours based upon our experience; however, 
the optimal period of time patched versus placing topical antibiotics the fIrst day is not known. 
4. Topical antibiotics should be considered frequently the day of surgery, possibly after four hours of 
patching. With increasing resistance to second generation fluoroquinolones it makes sense to use fourth 
generation fluoroquinolones every one to two hours on the first surgical day which would further enhance 
the collagen shield created ocular antibiotic level. Antibiotics should then be used regularly (ie: four times 
per day) for a week then discontinued to prevent over use and decrease development of bacterial resistance. 
5. The antibiotic should be a fluoroquinolone that can achieve adequate aqueous concentrations with excellent 
minimal inhibitory concentration ratios, fast kill rates and broad spectrum activity against key pathogens 
(especially gram positive organisms which represent all 20 of our positive cultures). 
6. If a wound leak is evident on the first postoperative day then a suture should probably be placed in the 
wound, and very frequent (every 30 minutes to one hour) topical fluoroquinolone (that readily penetrates 
into the eye) should be considered. Use of the same oral fluoroquinolone deserves consideration but also 
requires further scrutiny. The patient should be seen frequently and given a full explanation of the signs 
and symptoms of endophthalmitis. 
Important controversies remain unanswered. Our records did not allow clear differentiation between limbal and 
corneal incisions, so they were lumped together. We also had no records of antibiotic use prior to surgery other than 
when the patient arrived at the surgical center. Topical betadine was used in every patient without an iodine allergy. 
Both topical betadine and antibiotics used days before surgery are important in decreasing the bacterial load at the 
time of surgery, which may be important in the prevention of endophthalmitis9,lo. We also could not analyze the 
impact of switching to topical fluoroquinolones because 99+% were on them, nor could we analyze the impact of 
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Our visual acuity results were good for staphylococcal epiderrnidis with eight of twelve (67%) patients achieving 
20/50 or better vision post-infection. However, of the non-staphylococcal epiderrnides cases only two of eight 
(25%) were 20/50 or better and half ended up 20/200 or worse. Our experience also supports those studiesll ,12 
which show that endophthalmitis is not usually seen on the first postoperative day with only 2 of 27 so detected. On 
the fIrst postoperative day, the eyes that later developed endophthalmitis, unless there was an incision leak, were 
uniformly reported as normal. An eye which appears minimally inflamed on the first postoperative day can give a 
false sense of security and provides little information about whether or not endophthalmitis may follow. 
We feel this study gives important clues to the future prevention of endophthalmitis. Our most recent experience of 
only one case of endophthalmitis in 2002 (over 2500 cataract surgeries) is encouraging. This also suggests that with 
attention to the antibiotic (type and how used) and wound creation with suturing of marginal wounds, that clear 
corneal incisions can coexist with a low incidence of endophthalmitis. Other approaches suggested by this study are 
scleral wounds and sutures with corneal wounds. Which approach might be superior is controversial and can not be 
answered by this study We hope for a further decrease in endophthalmitis incidence with verification of our 
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CLINICALIEXPERIMENTAL STUDIES 
Human Subject Participation in Experimental Investigations: University of Utah IRE approval was obtained for 
all aspects of this study. 
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TABLES 
Table 1: Characteristics of control (N=1525), endophthalmitis (N=27) and culture positive (N=20) groups 
(control represents a 10% sampling of all patients). Raw numbers are in parenthesis. 
Category Control Group Endophthalmitis 
Group 
Age (Years) 74.3±14.3 72.2±17.5 
Gender (Female) 63.2% (964) 56% (15) 
Anesthesia (Topical) 85.8% (1308) 92.6% (25) 
Incision (LimbaI/Corneal) vs. Scleral 91.6% (1397) 100% (27) 
Location (Temporal) vs. Superior 91.9% (1401) 100% (27) 
Intraocular Lens (Acrylic) vs. Silicone 76.8% (1171) 68% (18) 
Collagen Shield Used* 57.5% (867) 37% (10) 
Eye Patchedt 41.7% (636) 11.1%(3) 
Incision Suturedt 9.0% (137) 22.2% (6) 
Capsular or Zonular Breakage§ 2.2% (36) 18.5% (5) 
Pre-operative Antibiotic (Ciprofloxacin) vs. 57.1 % (871) 66.7% (18) 
Ofloxacin 
Post-operative Antibiotic (Ciprofloxacin) vs. 47.3% (721) 66.7% (18) 
Ofloxacin 
Antibiotic Started Day of Surgery vs. Next Day 87.2% (1330) 88.5% (24) 
Incision Leak on First Post-operative Day II 0.7% (11) 11.1 % (3) 





P=O.OOl for all endophthalmitis cases and 0.004 for culture positive cases 
P=0.032 for all endophthalmitis cases and 0.013 for culture positive cases 
P<O.OOl for all endophthalmitis cases and for culture positive cases 
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Table 2. A multivariate regression analysis of all factors recorded in the endophthalmitis study. Scleral, and 
superior incision, as well as retrobulbar anesthesia categories were not included because they predict success 
perfectly (no cases of endophthalmitis). Culture positive results in parentheses. 
All Endopthalmitis Cases 
Category Odds Ratio ± the 95 % Confidence P Value 
C standard error Intervals 
C 
~ Age 0.98±.02 0.95 to 1.01 0.28 ~ 
> (1.00±.02) (0.96 to 1.05) (0.92) C 
rt 
:::r" 
0 Male Gender 1.52±0.67 0.64 to 3.59 0.34 h 
~ (1.07±0.56) (0.38 to 2.99) (0.90) ~ ~ 
C 
rJl Silicone Lens Used 2.63±1.29 1.01 to 6.85 0.048 (') 
~. 
""0 
rt (1.71±1.00) (0.54 to 5.40) (0.36) 
Collagen Shield Not Used 2.70±1.31 1.06 to 7.14 0.037 
(1.72±0.89) (0.61 to 5.0) (0.30) 
Eye Not Patched 7.14±5.61 1.47 to 36.4 0.015 
9.09±9.09) (1.33 to 62.5) (0.025) 
Eye Sutured 1.57±1.12 0.39 to 6.33 0.52 
(2. 16±1.72) (0.45 to 10.3) (0.334) 
Zonular or Capsular Complications 17.2±14.2 3.44 to 86.4 0.001 
(17.8±16.2) (3.01 to 105.4) (0.002) 
Ofloxacin rather than Ciprofloxacin 1.74±1.1O 0.50 to 6.01 0.38 
C used Pre-operatively (3.60±2.43) (0.96 to 13.5) (0.057) 
C Ciprofloxacin rather than Ofloxacin 5.26±3.60 1.41 to 20.0 0.014 ~ 
~ 
> used Post-operatively (7.14±5.61) (1.61 to32.3) (0.009) C 
rt 




(15.9±15.9) (2.27 to 111.0) (0.006) 
~ 
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